News

Medicines Australia will join the Executive Committee of CT:IQ to bring an important perspective to this multi-stakeholder initiative

A leader in neuroscience research in Australia joins the CT:IQ steering committee

Pivotal stakeholder providing excellence in oncology clinical trials joins the steering committee

We are delighted to welcome the Sydney Partnership for Health, Education, Research & Enterprise to the Steering Committee

One of the largest pharmaceutical companies in Australia joins CT:IQ

ICON Cancer Foundation hope to “form new collaborations and learn from other more experienced trial sites”…

Macquarie University join CT:IQ: “We are excited to be part of this much needed initiative to improve Clinical Trials in Australia…”

We are delighted to announce that St. Vincent’s Hospital in Melbourne will join the CT:IQ Steering Committee

A huge thank you to all those who attended the inaugural CT:IQ symposium

CT:IQ will be formally launched at the Royal Melbourne Hospital on Wednesday 16th May, 2018